www.csl.com Open in urlscan Pro
12.3.33.229  Public Scan

Form analysis
2 forms found in the DOM

GET /search

<form method="GET" action="/search" role="search" aria-label="inline search">
  <label class="search-control-label">Search</label>
  <div class="ui-component ui-input search large" data-type="text" data-name="ui-input" cid="ui-input-2530-4573">
    <button data-role="search" tabindex="0" aria-label="search" type="button"></button>
    <input type="text" name="q" value="" placeholder="Search" aria-label="Search" autocomplete="off">
    <button data-role="submit" tabindex="0" aria-label="submit" type="submit"></button>
  </div>
</form>

GET /search

<form method="GET" action="/search" role="search" aria-label="modal search dialog">
  <label class="search-control-label">Search</label>
  <div class="ui-component ui-input search large" data-type="text" data-name="ui-input" cid="ui-input-2530-1410">
    <button data-role="search" tabindex="0" aria-label="search" type="button"></button>
    <input type="text" name="q" aria-label="Search" value="" placeholder="Search" autocomplete="off">
    <button data-role="submit" tabindex="0" aria-label="submit" type="submit"></button>
  </div>
</form>

Text Content

Skip to main content
 * Global Selector
 * 
 * Newsroom
 * Partnering
 * Contact

 * We Are CSL
   We Are CSL
   Our Businesses and Products
   Vita: Original Stories
   CSL Podcasts
   Our Leadership
   Worldwide Locations
   Corporate Governance
   Our Businesses and Products
   CSL Behring
   CSL Plasma
   CSL Seqirus
   CSL Vifor
   Corporate Governance
   Code of Responsible Business Practice
   Core Policies
   
   Vita means life. It's also our platform for sharing the stories of biotech's
   promise to patients and public health.
   
   Read the Stories
   
   CSL consists of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor. Learn
   more by visiting each section.
   
   Our Businesses and Products
 * Patients & Public Health
   Patients & Public Health
   Rare & Serious Diseases
   Iron Deficiency
   Nephrology
   Vaccines
   Patient Support & Organizations
   Rare & Serious Diseases
   Immunodeficiency and Autoimmune Diseases
   Hereditary Bleeding Disorders
   Hereditary Angioedema
   Alpha 1 Antitrypsin Deficiency
   Iron Deficiency
   Iron Deficiency Patient Stories
   Nephrology
   Nephrology Patient Stories
   Vaccines
   Pandemic Response
   In-Licensing
   Antivenoms and Q fever Vaccine
   Patient Support & Organizations
   CSL Behring USA Support & Assistance Programs
   CSL Vifor Managed Access Programs
   LEAD Grants
   
   Biotechnology leader CSL Behring offers the broadest range of quality
   plasma-derived and recombinant therapies in our industry.
   
   CSL Behring: Rare & Serious Diseases
   
   Derived from the expression 'securing health for all of us', CSL Seqirus is
   one of the world's largest influenza vaccine providers.
   
   CSL Seqirus: Vaccines
 * R&D
   R&D
   R&D Capabilities
   Awards, Grants and Initiatives
   World-Class R&D Network
   Product Pipeline
   Clinical Studies at CSL
   Clinical Studies at CSL
   Current Clinical Trials
   Research Practices
   How to Participate
   Clinical Studies FAQs
   
   R&D focuses its expertise on four strategic platforms: plasma protein
   technology; recombinant technology; cell and gene therapy; and vaccines
   technology.
   
   R&D Capabilities
   
   One of our core values at CSL is Innovation. We support collaborative
   innovation through the endowment of awards and grants to researchers around
   the world.
   
   Awards, Grants and Initiatives
 * Sustainability
   Sustainability
   Environment
   Social
   Sustainable Workforce
   Governance
   Data and Reporting Centre
   Environment
   Climate Resilience
   Energy and Emissions
   Waste, Water and Packaging
   Social
   Product Safety & Quality
   Innovation and R&D
   Access & Health Security
   Responsible & Resilient Supply Chain
   Sustainable Workforce
   Providing A Positive Working Environment
   Health, Safety & Wellbeing
   Diversity, Equity & Inclusion
   Governance
   Ethics & Transparency
   Data Protection & Privacy
   Stakeholder Engagement & Material Topics
   Data and Reporting Centre
   Annual Publications
   Policies
   Key Performance Data Summary
   
   As part of our broader sustainability strategy to build a more sustainable
   future, we've committed to a 40% reduction in absolute Scope 1 and 2
   emissions by 2030.
   
   Learn About Our Targets
   
   Along with our sustainability strategy, CSL’s community contribution
   framework helps deliver on our Values and support execution of our 2030
   strategy.
   
   Supporting Our Communities
 * Careers
   Careers
   Diversity, Equity & Inclusion
   How CSL Supports Your Well-being
   Early Careers at CSL
   Early Careers at CSL
   Apprenticeships
   Internships at CSL
   Graduate Rotational Programs at CSL
   
   At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission
   and who we are. It fuels our innovation day in and day out.
   
   Read About Our DE&I
   
   Whether you are early in your college education or recently completed your
   degree, it's never too soon to consider CSL for your Promising Future!
   
   Early Careers at CSL
 * Investors
 * 
 * 

CSL
Back
Search


 * 

 * We Are CSL
    * We Are CSL
    * Our Businesses and Products
       * Our Businesses and Products
       * CSL Behring
       * CSL Plasma
       * CSL Seqirus
       * CSL Vifor
   
    * Vita: Original Stories
    * CSL Podcasts
    * Our Leadership
    * Worldwide Locations
    * Corporate Governance
       * Corporate Governance
       * Code of Responsible Business Practice
       * Core Policies

 * Patients & Public Health
    * Patients & Public Health
    * Rare & Serious Diseases
       * Rare & Serious Diseases
       * Immunodeficiency and Autoimmune Diseases
       * Hereditary Bleeding Disorders
       * Hereditary Angioedema
       * Alpha 1 Antitrypsin Deficiency
   
    * Iron Deficiency
       * Iron Deficiency
       * Iron Deficiency Patient Stories
   
    * Nephrology
       * Nephrology
       * Nephrology Patient Stories
   
    * Vaccines
       * Vaccines
       * Pandemic Response
       * In-Licensing
       * Antivenoms and Q fever Vaccine
   
    * Patient Support & Organizations
       * Patient Support & Organizations
       * CSL Behring USA Support & Assistance Programs
       * CSL Vifor Managed Access Programs
       * LEAD Grants

 * R&D
    * R&D
    * R&D Capabilities
    * Awards, Grants and Initiatives
    * World-Class R&D Network
    * Product Pipeline
    * Clinical Studies at CSL
       * Clinical Studies at CSL
       * Current Clinical Trials
       * Research Practices
       * How to Participate
       * Clinical Studies FAQs

 * Sustainability
    * Sustainability
    * Environment
       * Environment
       * Climate Resilience
       * Energy and Emissions
       * Waste, Water and Packaging
   
    * Social
       * Social
       * Product Safety & Quality
       * Innovation and R&D
       * Access & Health Security
       * Responsible & Resilient Supply Chain
   
    * Sustainable Workforce
       * Sustainable Workforce
       * Providing A Positive Working Environment
       * Health, Safety & Wellbeing
       * Diversity, Equity & Inclusion
   
    * Governance
       * Governance
       * Ethics & Transparency
       * Data Protection & Privacy
       * Stakeholder Engagement & Material Topics
   
    * Data and Reporting Centre
       * Data and Reporting Centre
       * Annual Publications
       * Policies
       * Key Performance Data Summary

 * Careers
    * Careers
    * Diversity, Equity & Inclusion
    * How CSL Supports Your Well-being
    * Early Careers at CSL
       * Early Careers at CSL
       * Apprenticeships
       * Internships at CSL
       * Graduate Rotational Programs at CSL

 * Investors
 * Newsroom
 * Partnering
 * Contact
 * Global Selector
 * 

)


CSL SEQIRUS

 * CSL
 * We Are CSL
 * Our Businesses and Products
 * CSL Seqirus


SECURING HEALTH FOR ALL OF US

Derived from the expression 'securing health for all of us', CSL Seqirus has
public health protection at its core. This reflects the promise of our parent
company CSL, founded in 1916 to save lives and protect the health of people. Our
first true test came with the Spanish Influenza Pandemic and we have been
committed to the fight against influenza ever since.

Influenza kills. But at CSL Seqirus, we believe it shouldn’t be that way. As the
only vaccine company with a singular global focus on influenza, we work
tirelessly on cutting-edge research, transformative technologies and the latest
methods of production and distribution. Together with our partners we’re on the
front line every day, protecting communities from seasonal influenza and global
pandemic threats.

Our vision is a world protected from influenza.


AREAS OF EXPERTISE


INFLUENZA VACCINES

We are one of the world’s largest influenza vaccine companies with a singular
global focus on influenza.

Learn More About Our Vaccines


PANDEMIC RESPONSE

Experts agree that there will be another influenza pandemic this century1. CSL
Seqirus offers a portfolio of pandemic vaccines and services for rapid response.

Learn More About Our Pandemic Response


IN-LICENSING

CSL Seqirus is the largest fully integrated commercialisation partner for
vaccines and pharmaceuticals in Australia and New Zealand.

Learn More About Our In-Licensing Programs


ANTIVENOMS AND Q FEVER VACCINE

CSL Seqirus is the supplier of a unique range of antivenoms and Q fever vaccine
for the Australian government.

Learn More About These Programs


OUR MANUFACTURING EXPERTISE

CSL Seqirus operates state-of-the-art manufacturing facilities in three
different continents and a globally integrated supply chain for the timely
supply of influenza vaccine to customers around the world.

Learn More About Our Manufacturing



OUR PRODUCTS

As a global leader in influenza protection, CSL Seqirus has one of the broadest
influenza vaccine portfolios in the world.

Learn More About Our Products


*World Health Organisation. Influenza (seasonal) Fact Sheet, November 2018.
Available online:
http://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal) (Accessed
October 2020)
^de Boer, P. et al, A systematic review of health economic consequences of
quadrivalent influenza vaccination, Expert review of Pharmacoeconomics &
Outcomes Research, Volume 17, 2017 - Issue 3, p249-265.
 https://www.tandfonline.com/doi/full/10.1080/14737167.2017.1343145 (Accessed
October 2020)
1 World Health Organisation. Newsroom Feature. 8 Things to know about pandemic
influenza. Available
online: https://www.who.int/news-room/feature-stories/detail/8-things-to-know-about-pandemic-influenza
(Accessed October 2020)

 

Terms of Use Cookie Policy Global Privacy Policy Accessibility Statement
Glossary Sitemap
 * Terms of Use
 * Cookie Policy
 * Global Privacy Policy
 * Accessibility Statement
 * Glossary
 * Sitemap

CSL, All Rights Reserved © 2023

 * 
 * 
 * 
 * 
 * 

Search


 * 


Play
PausePlay
Seek% buffered00:00
UnmuteMuteDisable captionsEnable captionsExit fullscreenEnter fullscreen
CSL
 * CSL (CSL Behring's Parent Company)

CSL Behring Worldwide

Americas

 * Argentina
 * Brazil
 * Canada
 * Chile
 * Colombia
 * CSL Behring Global
 * Mexico

Asia Pacific

 * Australia
 * China
 * Japan
 * Korea
 * Singapore
 * Taiwan

Middle East

 * Saudi Arabia
 * United Arab Emirates (MEA)

Europe

 * Austria
 * Belgium and Luxembourg
 * Czech Republic
 * Denmark
 * Finland
 * France
 * Germany
 * Greece
 * Hungary
 * Iceland
 * Italy
 * Netherlands
 * Norway
 * Poland
 * Slovakia
 * Spain
 * Sweden
 * Switzerland
 * Turkey
 * United Kingdom

CSL Plasma (CSL Behring Subsidiary)
 * CSL Plasma US
 * CSL Plasma Germany
 * CSL Plasma Hungary

By clicking “Accept All Cookies”, you agree to the storing of cookies on your
device to enhance site navigation, analyze site usage, and assist in our
marketing efforts.

Cookies Settings Reject All Accept All Cookies



PRIVACY PREFERENCE CENTER

When you visit any website, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalized web experience. Because we respect your right to
privacy, you can choose not to allow some types of cookies. Click on the
different category headings to find out more and change our default settings.
However, blocking some types of cookies may impact your experience of the site
and the services we are able to offer.
More information
Allow All


MANAGE CONSENT PREFERENCES

STRICTLY NECESSARY COOKIES

Always Active

These cookies are necessary for the website to function and cannot be switched
off in our systems. They are usually only set in response to actions made by you
which amount to a request for services, such as setting your privacy
preferences, logging in or filling in forms. You can set your browser to block
or alert you about these cookies, but some parts of the site will not then work.
These cookies do not store any personally identifiable information.

View Vendor Details‎

PERFORMANCE COOKIES

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site. All
information these cookies collect is aggregated and therefore anonymous. If you
do not allow these cookies we will not know when you have visited our site, and
will not be able to monitor its performance.

View Vendor Details‎

FUNCTIONAL COOKIES

Functional Cookies

These cookies enable the website to provide enhanced functionality and
personalisation. They may be set by us or by third party providers whose
services we have added to our pages. If you do not allow these cookies then some
or all of these services may not function properly.

View Vendor Details‎

TARGETING COOKIES

Targeting Cookies

These cookies may be set through our site by our advertising partners. They may
be used by those companies to build a profile of your interests and show you
relevant adverts on other sites. They do not store directly personal
information, but are based on uniquely identifying your browser and internet
device. If you do not allow these cookies, you will experience less targeted
advertising.

View Vendor Details‎
Back Button


VENDORS LIST



Search Icon
Filter Icon

Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label

Reject All Confirm My Choices